Rosacea: Clinical Trials

24 trials for Rosacea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed. 24 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 124Completed 24
Phase 25Completed 5

Follow Rosacea: new trials by email Literature Review of Rosacea trials Research Report on Rosacea

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.
Ivermectin Cream 1%, Soolantra™ Cream 1%, PrRosiver® Cream 1% - Rosacea
Phase 1CompletedSun Pharmaceutical Industries, Inc.8652025-12-092026-08-31
Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream
Ivermectin cream, Soolantra ® (Ivermectin) cream - Rosacea
Phase 1CompletedHumanis Saglık Anonim Sirketi442024-03-062024-08-20
Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial
minocycline combined with hydroxychloroquine, gabapentin 300mg bid, gabapentin 300mg tid - Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)
Phase 1CompletedFirst Affiliated Hospital of Chongqing Medical University502024-01-052026-01-05
Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks
Minocycline hydrochloride capsules, Placebo - Rosacea
Phase 1CompletedJourney Medical Corporation602022-09-302023-08-02
Topical Mitogenic-Activated Protein Kinase (MAPK) Inhibition in Rosacea
Trametinib - Rosacea, Erythematotelangiectatic
Phase 1CompletedAlbany Research Institute, Inc.122021-11-012023-05-30
Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties
Encapsulated Benzoyl Peroxide Cream - Papulopustular Rosacea
Phase 1CompletedSol-Gel Technologies, Ltd.312020-06-102023-04-18
CGB-400 for the Reduction of Facial Redness
CGB-400 - Rosacea
Phase 1CompletedCAGE Bio Inc.252018-10-262020-08-11
CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes
CGB-400 - Rosacea
Phase 1CompletedCAGE Bio Inc.272018-10-262020-08-12
To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea
Azelaic acid foam 15%, Finacea® (Azelaic acid Foam) 15%, Vehicle of the test product - Rosacea
Phase 1CompletedSun Pharmaceutical Industries, Inc.11162017-12-122019-03-19
Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea
Secukinumab - Papulopustular Rosacea
Phase 1 / Phase 2CompletedAnne Chang242017-06-212020-02-05
To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel
Azelaic Acid 15% topical gel, Finacea® (azelaic acid) Gel, 15%, Placebo - Rosacea
Phase 1CompletedSun Pharmaceutical Industries, Inc.10002016-07-012024-04-10
Pharmacokinetics of Doxycycline in Skin of Healthy Volunteers
Doxycycline - Rosacea
Phase 1CompletedMedical University of Vienna62016-07-012018-03-27
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
Ivermectin - Rosacea
Phase 1 / Phase 2CompletedUniversity of California, San Diego252016-07-012021-10-05
Timolol for the Treatment of Acne and Rosacea
Timolol - Acne Vulgaris, Rosacea
Phase 1CompletedJohns Hopkins University82016-03-012021-11-11
A 21 Day Pharmacokinetics Study in Papulopustular Rosacea
CLS001 - Papulopustular Rosacea
Phase 1CompletedMaruho Co., Ltd.252014-01-012014-04-14
An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema
Cromolyn Sodium, Normal Saline - Papulopustular Rosacea
Phase 1 / Phase 2CompletedUniversity of California, San Diego102013-08-012019-08-07
Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea
AGN-199201 Formulation A, AGN-199201 Formulation B, AGN-199201 Formulation C - Rosacea, Erythema
Phase 1CompletedAllergan642012-04-012019-11-18
A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155)
Laropiprant, Placebo for Laropiprant - Rosacea
Phase 1CompletedMerck Sharp & Dohme LLC602011-11-012015-03-25
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Metronidazole Topical Gel 1%, Metronidazole Topical Gel 1% (Metrogel), Placebo - Rosacea
Phase 1CompletedSun Pharmaceutical Industries, Inc.6022011-08-012013-12-23
Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
Azelaic Acid Foam, Azelaic Acid Gel - Papulopustular Rosacea
Phase 1CompletedLEO Pharma212011-01-012023-06-09

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Acne Vulgaris (2)  ·  Erythema (2)  ·  Telangiectasis (2)  ·  Corneal Neovascularization (1)  ·  Flushing (1)

Broader conditions

Skin Diseases (24)  ·  Skin and Connective Tissue Diseases (24)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Acneiform Eruptions (2)  ·  Cardiovascular Diseases (2)  ·  Sebaceous Gland Diseases (2)  ·  Signs and Symptoms (2)  ·  Skin Manifestations (2)  ·  Vascular Diseases (2)  ·  Corneal Diseases (1)  ·  Eye Diseases (1)  ·  Metaplasia (1)  ·  Neovascularization, Pathologic (1)  ·  Pathologic Processes (1)

Interventions

Ivermectin (2)  ·  azelaic acid (2)  ·  BID protein, human (1)  ·  Calcium Dobesilate (1)  ·  Cromolyn Sodium (1)  ·  Doxycycline (1)  ·  Gabapentin (1)  ·  Gels (1)  ·  Hydroxychloroquine (1)  ·  Lasers, Dye (1)  ·  MK-0524 (1)  ·  Metronidazole (1)  ·  Minocycline (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Sponsors

Sun Pharmaceutical Industries, Inc. (4)  ·  CAGE Bio Inc. (2)  ·  University of California, San Diego (2)  ·  Albany Research Institute, Inc. (1)  ·  Allergan (1)  ·  Anne Chang (1)  ·  Ellen Marmur (1)  ·  First Affiliated Hospital of Chongqing Medical University (1)  ·  Humanis Saglık Anonim Sirketi (1)  ·  Johns Hopkins University (1)  ·  Journey Medical Corporation (1)  ·  LEO Pharma (1)  ·  Maruho Co., Ltd. (1)  ·  Mayo Clinic (1)  ·  Medical University of Vienna (1)

Countries

United States (19)  ·  Austria (1)  ·  China (1)  ·  India (1)

Top investigators

Natalie Yantovskiy (2)  ·  Anne Chang, MD (1)  ·  Ellen Marmur, MD (1)  ·  Gerald D Weinstein, MD (1)  ·  Jacqueline Busingye, MD (1)  ·  Luis A Garza, MD, PhD (1)  ·  Mark V. Dahl, M.D. (1)  ·  Markus Zeitlinger (1)  ·  Reza Dana, MD, MPH, MSc (1)  ·  Srinivas Sidgiddi, M.D. (1)  ·  Tissa Hata, MD (1)

Results publications

PMID 23233252, PMID 25142778, PMID 32360760, PMID 32989925, PMID 33548303, PMID 34840653, PMID 35385049, PMID 35929658, PMID 39136023, PMID 39148964, PMID 39681269, PMID 39710117